{
    "clinical_study": {
        "@rank": "30246", 
        "arm_group": [
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "Other", 
                "description": "Control group will be administered oxytocin and placebo, in a double-blind randomized order."
            }, 
            {
                "arm_group_label": "congenital prosopagnosia (CP)", 
                "arm_group_type": "Experimental", 
                "description": "CP will be administered oxytocin and placebo in a double-blind randomized order."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether oxytocin affect face perception"
        }, 
        "brief_title": "The Effect of Oxytocin on Face Perception", 
        "condition": [
            "Healthy", 
            "Congenital Prosopagnosia"
        ], 
        "condition_browse": {
            "mesh_term": "Prosopagnosia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  normal or corrected to normal vision\n\n        Exclusion Criteria:\n\n          -  minors\n\n          -  pregnancy (according to a pregnancy test taken by subjects prior to participation)\n\n          -  a history of asthma or nasal polyps\n\n          -  cardiac disorders\n\n          -  hyponatremia\n\n          -  acute or chronic renal insufficiency\n\n          -  liver cirrhosis\n\n          -  neurological disease\n\n          -  other chronic disease\n\n          -  dementia, or lack of judgment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 26, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02091817", 
            "org_study_id": "sor010712ctil", 
            "secondary_id": "ISF, 384/10"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Control group", 
                    "congenital prosopagnosia (CP)"
                ], 
                "description": "Intervention will be examined on control group, and on experimental group as well.", 
                "intervention_name": "Oxytocin", 
                "intervention_type": "Drug", 
                "other_name": "syntocinon"
            }, 
            {
                "arm_group_label": [
                    "Control group", 
                    "congenital prosopagnosia (CP)"
                ], 
                "description": "Placebo will be given to control group and experimental group as well.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Oxytocin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "oxytocin", 
            "face", 
            "memory"
        ], 
        "lastchanged_date": "March 17, 2014", 
        "location": {
            "contact": {
                "email": "weissnil@post.bgu.ac.il", 
                "last_name": "Weiss, M.A"
            }, 
            "facility": {
                "address": {
                    "city": "Beer Sheva", 
                    "country": "Israel"
                }, 
                "name": "Soroka medical center"
            }, 
            "investigator": {
                "last_name": "Ilan Shelef, Dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Behavioral and Neural Effects of Oxytocin on Face Perception in Congenital Prosopagnosia", 
        "overall_official": [
            {
                "affiliation": "Soroka University Medical Center", 
                "last_name": "Shelef Ilan, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ben-Gurion University of the Negev", 
                "last_name": "Galia Avidan, Ph.D", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "At the day participants will administer the substance, they will view a set of faces, of which they will be tested about 24 hours later. The measures that will be tested are accuracy and eye movements.", 
            "measure": "Memory performance", 
            "safety_issue": "No", 
            "time_frame": "24 hours after encoding"
        }, 
        "reference": [
            {
                "PMID": "19481456", 
                "citation": "Avidan G, Behrmann M. Functional MRI reveals compromised neural integrity of the face processing network in congenital prosopagnosia. Curr Biol. 2009 Jul 14;19(13):1146-50. doi: 10.1016/j.cub.2009.04.060. Epub 2009 May 28."
            }, 
            {
                "PMID": "19334309", 
                "citation": "Avidan G, Behrmann M. Implicit familiarity processing in congenital prosopagnosia. J Neuropsychol. 2008 Mar;2(Pt 1):141-64."
            }, 
            {
                "PMID": "16102242", 
                "citation": "Avidan G, Hasson U, Malach R, Behrmann M. Detailed exploration of face-related processing in congenital prosopagnosia: 2. Functional neuroimaging findings. J Cogn Neurosci. 2005 Jul;17(7):1150-67."
            }, 
            {
                "PMID": "16102241", 
                "citation": "Behrmann M, Avidan G, Marotta JJ, Kimchi R. Detailed exploration of face-related processing in congenital prosopagnosia: 1. Behavioral findings. J Cogn Neurosci. 2005 Jul;17(7):1130-49."
            }, 
            {
                "PMID": "12729493", 
                "citation": "Hasson U, Avidan G, Deouell LY, Bentin S, Malach R. Face-selective activation in a congenital prosopagnosic subject. J Cogn Neurosci. 2003 Apr 1;15(3):419-31."
            }, 
            {
                "PMID": "21429671", 
                "citation": "MacDonald E, Dadds MR, Brennan JL, Williams K, Levy F, Cauchi AJ. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology. 2011 Sep;36(8):1114-26. doi: 10.1016/j.psyneuen.2011.02.015. Epub 2011 Mar 23. Review."
            }, 
            {
                "PMID": "23377287", 
                "citation": "Avidan G, Tanzer M, Hadj-Bouziane F, Liu N, Ungerleider LG, Behrmann M. Selective Dissociation Between Core and Extended Regions of the Face Processing Network in Congenital Prosopagnosia. Cereb Cortex. 2013 Jan 31. [Epub ahead of print]"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02091817"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Soroka University Medical Center", 
            "investigator_full_name": "Ilan Shelef", 
            "investigator_title": "Head of medical imaging at Soroka University Medical Center", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Participants will fill a PANAS mood questionnaire just before oxytocin/placebo uptake, and 45 minutes after oxytocin/placebo uptake, in order to monitor the effects of mood and fatigue of oxytocin/placebo.", 
            "measure": "Mood measurement", 
            "safety_issue": "No", 
            "time_frame": "Before oxytocin/placebo uptake, and 45 min. after"
        }, 
        "source": "Soroka University Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Ben-Gurion University of the Negev", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Soroka University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}